Search Result "Tryptophan catabolites."
Tryptophan Catabolites and Migraine
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 1013-1021
Author(s): Zsuzsanna Bohár,Ãrpád Párdutz,László Vécsei
Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 1074-1085
Author(s): Michael Maes,George Anderson
Serum Tryptophan, Tryptophan Catabolites and Brain-derived Neurotrophic Factor in Subgroups of Youngsters with Autism Spectrum Disorders
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17 Issue: 8 Year: 2018 Page: 634-647
Author(s): Heidi Ormstad,Vesna Bryn,Robert Verkerk,Ola H. Skjeldal,Bente Halvorsen,Ola Didrik Saugstad,Jorn Isaksen,Michael Maes
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 1049-1059
Author(s): Jens O. Watzlawik,Bharath Wootla,Moses Rodriguez
Oxidative and Nitrosative Stress, Immune Inflammation and Trptophan Catabolites in Driving Melatonergic Pathway Alterations in Depression: Treatment Implications
Ebook: Frontiers in Drug Discovery
Volume: 2 Year: 2017
Author(s): George Anderson,Michael Maes
Doi: 10.2174/9781681084732117020012
Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Journal: Current Neuropharmacology
Volume: 12 Issue: 2 Year: 2014 Page: 148-167
Author(s): George Anderson,Michael Maes
Depression, Serotonin and Tryptophan
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 949-954
Author(s): Liliana DellâOsso,Claudia Carmassi,Federico Mucci,Donatella Marazziti
Gut Permeability and Microbiota in Parkinsonâs Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 40 Year: 2016 Page: 6142-6151
Author(s): George Anderson,Moonsang Seo,Michael Berk,Andre F. Carvalho,Michael Maes
The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 8 Year: 2016 Page: 963-977
Author(s): Gerwyn Morris,André F. Carvalho,George Anderson,Piotr Galecki,Michael Maes
IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 4 Year: 2017 Page: 472-483
Author(s): Chutima Roomruangwong,Buranee Kanchanatawan,Sunee Sirivichayakul,George Anderson,Andre F. Carvalho,Sebastien Duleu,Michel Geffard,Michael Maes